AstraZeneca PLC

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:07 2024-06-14 am EDT			5-day change	1st Jan Change
12,510 ^GBX	+0.95%		-0.37%	+18.02%

Jun. 14	European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading	MT
Jun. 13	Tesla, Inc. : Musk moves a step closer to the $56 billion prize and the transfer of Tesla's headquarters to Texas

AstraZeneca : EU chief says vaccine maker AstraZeneca to supply 9 million more doses, begin delivery sooner after urgent talks

January 31, 2021 at 02:40 pm EST

BERLIN (AP) — EU chief says vaccine maker AstraZeneca to supply 9 million more doses, begin delivery sooner after urgent talks.

Latest news about AstraZeneca PLC

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading	Jun. 14	MT
Tesla, Inc. : Musk moves a step closer to the $56 billion prize and the transfer of Tesla's headquarters to Texas	Jun. 13
AstraZeneca: Farxiga approved for diabetes as of age 10	Jun. 13	CF
AstraZeneca's Type-2 Diabetes Drug Wins Pediatric Approval in US	Jun. 12	MT
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.	Jun. 12	DJ
AstraZeneca Gets FDA Approval for Pediatric Type-2 Diabetes Control Drug	Jun. 12	MT
AstraZeneca's Farxiga approved to treat paediatric type-2 diabetes	Jun. 12	AN
European Equities Close Lower in Monday Trading Following Far Right Gains in EU Elections	Jun. 10	MT
UK Stocks Join Europe Retreat Ahead of US Fed Rate Decision	Jun. 10	MT
ASTRAZENECA : Berenberg raises its price target	Jun. 10	CF
AstraZeneca shares outperform, Berenberg raises target	Jun. 10	CF
Berenberg Raises AstraZeneca PT, Maintains Buy Rating	Jun. 10	MT
AstraZeneca's Tagrisso Secures Priority Review in the US	Jun. 10	MT
Berenberg Raises Price Target on AstraZeneca to GBP150 From GBP130, Cites More Confidence in Longer-Term Outlook, Keeps Buy Rating	Jun. 10	MT
JPMorgan cuts Aviva but lifts M&G	Jun. 10	AN
Investors remain cautious as political instability takes over Europe	Jun. 10
AstraZeneca: priority review in the USA for Tagrisso	Jun. 10	CF
Astra's Tagrisso gets US priority review for lung cancer	Jun. 10	AN
FTSE called down amid political uncertainty in EU	Jun. 10	AN
AstraZeneca Wins US FDA's Priority Review Tag for Expanded Use of Lung Cancer Drug	Jun. 10	MT
ASTRAZENECA : Berenberg gives a Buy rating	Jun. 10	ZD
ASTRAZENECA : JP Morgan reiterates its Buy rating	Jun. 07	ZD
Department of Health - Abu Dhabi and AstraZeneca Expand Partnership During Bio International Convention 2024 to Establish New Rare Diseases Centre of Excellence	Jun. 05	CI
HSBC Raises AstraZeneca PT, Keeps Buy Rating	Jun. 05	MT
ASTRAZENECA : Deutsche Bank remains Neutral	Jun. 05	ZD

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Sector

Pharmaceuticals

Calendar

2024-07-25 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR) , FTSE 100

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm EDT

More Strategies

Ratings for AstraZeneca PLC

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

158.6 USD

Average target price

174.4 USD

Spread / Average Target

+9.95%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ASTRAZENECA PLC	+18.02%	246B
NOVO NORDISK A/S	+41.96%	630B
JOHNSON & JOHNSON	-7.15%	350B
MERCK & CO., INC.	+18.77%	328B
ABBVIE INC.	+8.79%	298B
ROCHE HOLDING AG	+1.27%	225B
NOVARTIS AG	+11.95%	218B
AMGEN INC.	+3.68%	160B
PFIZER, INC.	-4.38%	156B
SANOFI	-3.71%	116B

Other Pharmaceuticals

AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

AstraZeneca : EU chief says vaccine maker AstraZeneca to supply 9 million more doses, begin delivery sooner after urgent talks

Latest news about AstraZeneca PLC

Chart AstraZeneca PLC

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for AstraZeneca PLC

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals